Skip to main content
. 2020 Mar 14;19:111. doi: 10.1186/s12936-020-03184-x

Fig. 3.

Fig. 3

Neuropsychiatric adverse events occurring before day 29 in P. vivax patients given tafenoquine/chloroquine versus placebo/chloroquine [9, 10]